Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A
5(83.3%)
Phase 4
1(16.7%)
6Total
N/A(5)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07063381Not ApplicableNot Yet Recruiting

Low-frequency Electrical Stimulation for Cognitive Enhancement in Atrial Fibrillation

Role: lead

NCT06281795Not ApplicableRecruiting

Neuromodulation of the Autonomic Nervous System in Athletes

Role: lead

NCT06253000Not ApplicableRecruiting

Radiofrequency and Cryoablation of the Posterior Wall of the Left Atrium

Role: lead

NCT05992259Not ApplicableRecruiting

Auricular Vagus Stimulation and STEMI

Role: lead

NCT05680337Not ApplicableRecruiting

Auricular Vagus Stimulation and Heart Rate Variability

Role: lead

NCT04224545Phase 4Completed

COlchicine in Cardiac Surgery

Role: lead

NCT02361996Suspended

Quantitative Measurement of Myocardial Perfusion by Cardiac CT in Patients

Role: lead

All 7 trials loaded